Procurement Summary
Country : USA
Summary : TECHNOLOGY TRANSFER OPPORTUNITY: Simulated Space Station Environment for Cell Cultures (LAR-TOPS-199)
Deadline : 17 Mar 2021
Other Information
Notice Type : Tender
TOT Ref.No.: 41681702
Document Ref. No. : T2P-LaRC-00049
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
Contracting Office Address : WASHINGTON, DC 20546
Primary Point of Contact : Langley Research Center
LARC-DL-technologygateway@mail.nasa.gov
USA
Email :larc-dl-technologygateway@mail.nasa.gov
Tender Details
TECHNOLOGY TRANSFER OPPORTUNITY: Simulated Space Station Environment for Cell Cultures (LAR-TOPS-199)
Active Contract Opportunity
Notice ID : T2P-LaRC-00049
Related Notice
Department/Ind. Agency : NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
Sub-tier : NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
Office : NASA HEADQUARTERS
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Mar 18, 2020 09:13 am EDT
Original Response Date: Mar 17, 2021 05:00 pm EDT
Inactive Policy: 15 days after response date
Original Inactive Date: Apr 01, 2021
Initiative: None
Classification
Original Set Aside:
Product Service Code: 9999 - MISCELLANEOUS ITEMS
NAICS Code: 927110 - Space Research and Technology
Place of Performance:
Description
NASA s Technology Transfer Program solicits inquiries from companies interested in obtaining license rights to commercialize, manufacture and market the following technology. License rights may be issued on an exclusive or nonexclusive basis and may include specific fields of use. NASA provides no funding in conjunction with these potential licenses.
THE TECHNOLOGY:
NASA Langley Research Center has developed a method and apparatus to be used for cell culture that combines the effects of microgravity and low dose radiation. The technology has been developed to simulate the effects of microgravity and chronic radiation exposure to cell culture experiments conducted on the International Space Station (ISS).
Recent experiments conducted aboard the ISS have led to the rapid development of vaccine candidates for infectious diseases, including MRSA and salmonella. This is due to activation of biological pathways and expression of biomarkers indicative of enhanced virulence that are not normally observed in terrestrial environments. The technology integrates a radiation source with a microgravity-simulating rotating-wall vessel for cell cultures to express enhanced virulence or otherwise unexpressed biological pathways that could potentially assist in drug development efforts. The invention more closely mimics the ISS environment than microgravity bioreactors that are currently commercially available.
To express interest in this opportunity, please submit a license application through NASA s Automated Technology Licensing Application System (ATLAS) by visiting https://technology.nasa.gov/patent/LAR-TOPS-199
If you have any questions, please contact Langley Research Center at LARC-DL-technologygateway@mail.nasa.gov with the title of this Technology Transfer Opportunity as listed in this FBO notice and your preferred contact information. For more information about licensing other NASA-developed technologies, please visit...
Documents
Tender Notice